Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
subcutaneous
Pharma
Merck scores FDA approval for subcutaneous Keytruda
Merck plans to launch Keytruda Qlex soon despite an ongoing patent dispute with Halozyme.
Angus Liu
Sep 19, 2025 4:54pm
Roche's high-dose version of Ocrevus flunks phase 3 trial
Apr 2, 2025 3:26pm
Merck lays out subcutaneous Keytruda data amid patent brawl
Mar 27, 2025 11:00am
AstraZeneca inks $1.35B deal for subcutaneous cancer drugs
Mar 17, 2025 10:55am
Gilead's PrEP shows early promise in once-yearly dosing
Mar 11, 2025 2:30pm
Merck, Halozyme dig in for patent fight over injectable Keytruda
Mar 6, 2025 11:18am
